Last $10.92 USD
Change Today -0.71 / -6.13%
Volume 10.4M
ACHN On Other Exchanges
As of 3:17 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael D. Kishbauch

Director and Chairman of Strategy & Corporate Development Committee, Achillion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 43 board members in 3 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Michael D. Kishbauch, also known as Mike, served as the Chief Executive Officer and President of Achillion Pharmaceuticals, Inc., Inc. from July 2004 to May 2013. Mr. Kishbauch founded of OraPharma, Inc., and served as its President and Chief Executive Officer since September 1996 and again from September 2000 to July 2004. He joined J&J and served as its President of the OraPharma division. He served as President and Chief Operating Officer at two business units ...

Read Full Background

Corporate Headquarters*

300 George Street
New Haven, Connecticut 06511

United States

Phone: 203-724-6000
Fax: 203-624-7003

Board Members Memberships*

Chief Executive Officer, President and Director
Former Director, Member of Compensation Committee and Member of the Audit Committee
Director and Chairman of Strategy & Corporate Development Committee
Director, Member of Compensation Committee and Member of Audit Committee


Wesleyan University
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$271,876

Stock Options*

All Other Compensation$7,911
Exercisable Options1,027,749
Exercisable Options Value$445,811
Total Value of Options$445,811
Total Number of Options1,027,749

Total Compensation*

Total Annual Cash Compensation$391,296
Total Short Term Compensation$271,876
Other Long Term Compensation$7,911
Total Calculated Compensation$460,683
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACHN:US $10.92 USD -0.71


Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
M. Michelle Berrey M.D., MPH.Chief Executive Officer, President, Chief Medical Officer and Director
Chimerix, Inc.
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACHILLION PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at